MedTrace Logo

The FAVOR II China Study

NCT03191708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 308

Last updated 2017-07-26

No results posted yet for this study

Summary

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. The purpose of the FAVOR II China study is to evaluate the diagnostic accuracy of on-line QFR with FFR as the reference standard. The secondary purpose is to compare the diagnostic accuracies between online QFR and online QCA, with FFR as the reference standard.

Conditions

Interventions

DIAGNOSTIC_TEST

Fractional Flow Reserve (FFR)

FFR measured by pressure wire, QFR computed by coronary angiographic images

Sponsors & Collaborators

  • Pulse Medical Imaging Technology (Shanghai) Co., Ltd

    collaborator INDUSTRY

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-13
Primary Completion
2017-07-20
Completion
2017-07-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03191708 on ClinicalTrials.gov